X

Drug Profile

Human angiotensin II

Alternative Names: (Asp1-Ile5) angiotensin II; Angiotensin II (human); Delivert; TY 10721

Latest Information Update: 11 Apr 2005

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Toa Eiyo
Developer Astellas Pharma; Toa Eiyo
Class Angiotensins; Antineoplastics; Peptide fragments; Vasopressors
Mechanism of Action Undefined mechanism

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Marketed Cancer

Most Recent Events

11 Apr 2005 Yamanouchi has merged with Fujisawa to form Astellas Pharma
28 Nov 2000 Profile reviewed but no significant changes made
17 Jul 1998 TY 10721 is now called human angiotensin II

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com